Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Quarterly results
Auditor change
|
|
Eledon Pharmaceuticals, Inc. (NVUS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
3
| Robinson James A. Jr. (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 10/02/2023 |
3
| Kirk Allan (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 01/31/2022 |
3
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 07/09/2021 |
3
| Hillson Jan (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 04/20/2021 |
3
| Smith Bryan E. (See Remarks) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 03/19/2021 |
3
| Little Paul Sean (CFO) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 12/14/2020 |
3
| Lee June (Director) has filed a Form 3 on Novus Therapeutics, Inc. |
| 11/06/2020 |
3
| Logos Global Management LP (10% Owner) has filed a Form 3 on Novus Therapeutics, Inc. |
| 10/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/24/2020 |
3
| Ogier Walter C (Director) has filed a Form 3 on Novus Therapeutics, Inc. |
| 09/15/2020 |
3
| Gros David-Alexandre C (CEO) has filed a Form 3 on Novus Therapeutics, Inc. |
| 03/20/2018 |
3
| LIFESCI INDEX PARTNERS LLC (10% Owner) has filed a Form 3 on Novus Therapeutics, Inc. |
| 07/10/2017 |
3
| Kuwahara Jon (See Remarks) has filed a Form 3 on Novus Therapeutics, Inc. |
| 05/11/2017 |
3
| Chimovits Erez (Director) has filed a Form 3 on Novus Therapeutics, Inc. |
| 05/11/2017 |
3
| LYONS GARY A (Director) has filed a Form 3 on Novus Therapeutics, Inc. |
| 05/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/11/2017 |
3
| Katkin Keith (Director) has filed a Form 3 on Novus Therapeutics, Inc. |
| 05/11/2017 |
3
| FLESHER GREGORY J. (CEO) has filed a Form 3 on Novus Therapeutics, Inc. |
| 05/11/2017 |
3
| TURKEL CATHERINE C. (Chief Development Officer) has filed a Form 3 on Novus Therapeutics, Inc. |
| 05/11/2017 |
3
| OrbiMed Israel GP Ltd. (10% Owner) has filed a Form 3 on Novus Therapeutics, Inc. |
|
|